SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type
- Resource Type
- Article
- Source
- In
Leukemia Research September 2020 96 - Subject
- Language
- ISSN
- 0145-2126